Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Durata Therapeutics Company Profile (NASDAQ:DRTX)

Consensus Ratings for Durata Therapeutics (NASDAQ:DRTX) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $22.02 (8.87% downside)

Analysts' Ratings History for Durata Therapeutics (NASDAQ:DRTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/15/2014Roth CapitalDowngradeBuy -> Neutral$23.00ViewTweet This Rating  Share This Rating on StockTwits
10/14/2014Credit SuisseDowngradeOutperform -> Neutral$25.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014ZacksUpgradeNeutral -> Outperform$29.10ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014RBC CapitalDowngradeOutperform -> Sector PerformViewTweet This Rating  Share This Rating on StockTwits
10/6/2014JMP SecuritiesDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
10/6/2014Roth CapitalSet Price Target$26.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Jefferies GroupLower Price Target$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2014Roth CapitalBoost Price Target$24.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2014GabelliInitiated CoverageHoldViewTweet This Rating  Share This Rating on StockTwits
6/19/2014JMP SecuritiesReiterated RatingOutperform$19.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Roth CapitalBoost Price TargetBuy$21.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014RBC CapitalBoost Price TargetOutperform$19.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Jefferies GroupBoost Price TargetHold$14.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
5/23/2014MLV & Co Initiated CoverageBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014MLV & Co Initiated CoverageBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
4/9/2014Summer StreetInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014Roth CapitalBoost Price Target$20.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014RBC CapitalBoost Price TargetOutperform$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014Jefferies GroupBoost Price Target$12.40 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
3/25/2014JMP SecuritiesBoost Price TargetOutperform$14.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
3/17/2014Jefferies GroupBoost Price Target$10.00 -> $12.40ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014Roth CapitalInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014Craig HallumInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/2/2013WedbushDowngradeOutperform -> Neutral$13.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013Janney Montgomery ScottInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
9/13/2013Jefferies GroupInitiated CoverageHold$10.00ViewTweet This Rating  Share This Rating on StockTwits
9/11/2013JMP SecuritiesBoost Price TargetMarket Outperform$12.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013WedbushLower Price Target$17.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013JMP SecuritiesInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
5/4/2013Ativo ResearchInitiated CoverageMost UnfavorableViewTweet This Rating  Share This Rating on StockTwits
4/12/2013WedbushLower Price TargetOutperform$26.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
3/15/2013Credit SuisseInitiated CoverageOutperform$15.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013WedbushBoost Price Target$20.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2013Bank of AmericaReiterated RatingBuy$12.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)